ES2096557T3 - Lectinas 14-beta-gal de mamiferos. - Google Patents

Lectinas 14-beta-gal de mamiferos.

Info

Publication number
ES2096557T3
ES2096557T3 ES89303714T ES89303714T ES2096557T3 ES 2096557 T3 ES2096557 T3 ES 2096557T3 ES 89303714 T ES89303714 T ES 89303714T ES 89303714 T ES89303714 T ES 89303714T ES 2096557 T3 ES2096557 T3 ES 2096557T3
Authority
ES
Spain
Prior art keywords
lectin
beta
gal
lectines
mamiferos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89303714T
Other languages
English (en)
Inventor
Glenn E Nedwin
Timothy S Bringman
Pierre-Olivier Couraud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2096557T3 publication Critical patent/ES2096557T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A LECTINA HL - 60 HUMANA QUE TIENE UNA SECUENCIA DE AMINOACIDOS DIFERENTE DE LA DE OTRAS LECTINAS ANIMALES CONOCIDAS. ESTA ES UN MIEMBRO DE UNA CLASE DE LECTINAS DE MAMIFEROS EXTRAIBLES EN LACTOSA O DETERGENTE Y ESPECIFICAS PARA BETA - D GALACTOSIDOS (LECTINA 14 - BETA - GAL QUE CONTIENE AL MENOS UN SITIO DE GLICOSILACION). TAMBIEN SE DESCRIBEN METODOS Y MATERIALES RECOMBINANTES PARA LA PRODUCCION DE LAS LECTINAS 14 - BETA - GAL DE MAMIFEROS, ESPECIALMENTE DE LECTINA HL - 60, EN UNA VARIEDAD DE HUESPEDES, Y METODOS PARA UTILIZAR LAS LECTINAS RESULTANTES. LA LECTINA HL - 60 HUMANA SE ENCUENTRA EN CELULAS HL - 60 Y EN TEJIDO PLACENTARIO.
ES89303714T 1988-04-14 1989-04-14 Lectinas 14-beta-gal de mamiferos. Expired - Lifetime ES2096557T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18174788A 1988-04-14 1988-04-14
US26373488A 1988-10-28 1988-10-28
US31364989A 1989-02-21 1989-02-21

Publications (1)

Publication Number Publication Date
ES2096557T3 true ES2096557T3 (es) 1997-03-16

Family

ID=27391456

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89303714T Expired - Lifetime ES2096557T3 (es) 1988-04-14 1989-04-14 Lectinas 14-beta-gal de mamiferos.

Country Status (8)

Country Link
US (1) US5587460A (es)
EP (1) EP0337799B1 (es)
JP (1) JP2983224B2 (es)
AU (1) AU632474B2 (es)
CA (1) CA1338878C (es)
DE (1) DE68926916T2 (es)
ES (1) ES2096557T3 (es)
GR (1) GR3021552T3 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651581B1 (fr) * 1989-09-06 1994-05-13 Centre Nal Recherc Scientifique Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques.
GB9023907D0 (en) * 1990-11-02 1990-12-12 Mallucci Livio Cell growth inhibitors
EP0611306B1 (en) * 1991-11-08 1998-07-08 Somatogen, Inc. Hemoglobins as drug delivery agents
US6406679B1 (en) * 1992-11-16 2002-06-18 Incyte Pharmaceuticals, Inc. Use of HL-60-related lectins in drug delivery and detection of lectin-expressing cells
US5433614A (en) * 1993-10-13 1995-07-18 Beye; Rick A. Method of instructing/tutoring using full motion tutor/instructor personage in window superimposed on educational material
FR2741883B1 (fr) * 1995-12-05 1998-02-20 Ass Pour Le Dev De La Biothera Composes possedant des proprietes lectiniques, et leurs applications biologiques
WO1998008535A2 (en) * 1996-08-26 1998-03-05 Incyte Pharmaceuticals, Inc. Method of causing selective immunosuppression using hl-60-related lectins
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
US6054315A (en) * 1997-09-05 2000-04-25 The Board Of Regents Of The University Of Oklahoma Method for making activated neutrophils recognizable to macrophages
US5948628A (en) 1997-09-05 1999-09-07 The Board Of Regents Of The University Of Oklahoma Methods of screening for compounds which mimic galectin-1
WO1999012041A1 (en) * 1997-09-05 1999-03-11 The Board Of Regents Of The University Of Oklahoma Composition and methods using galectin-1
EP1122311A4 (en) * 1998-07-31 2002-04-17 Kirin Brewery MEDICINES FOR TREATING NEUROPATHY CONTAINING GALECTIN-1 OR DERIVATIVES THEREOF AS ACTIVE SUBSTANCE
DE10149030A1 (de) * 2001-10-05 2003-04-10 Viscum Ag Stabile galenische gefriergetrocknete Arzneimittelzubereitung von rViscumin
AU2011211337B2 (en) * 2003-10-16 2014-10-02 Cancure Limited Immunomodulating compositions and uses therefor
EP2591786B1 (en) * 2003-10-16 2017-04-12 Cancure Limited Immunomodulating compositions and uses therefor
US7994113B2 (en) * 2007-06-14 2011-08-09 Livio Mallucci βGBP, compositions comprising βGBP, and related methods and uses thereof
GB2450146A (en) * 2007-06-14 2008-12-17 Livio Mallucci ßGBP, compositions comprising ßGBP, and related methods and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184020A (ja) * 1984-03-02 1985-09-19 Seikagaku Kogyo Co Ltd ヒト由来レクチン及びその採取法
JPH01110698A (ja) * 1987-03-31 1989-04-27 Kenichi Kasai ヒト胎盤又は臍帯由来レクチン

Also Published As

Publication number Publication date
EP0337799A2 (en) 1989-10-18
AU3304989A (en) 1989-10-19
AU632474B2 (en) 1993-01-07
DE68926916T2 (de) 1997-01-30
EP0337799B1 (en) 1996-08-07
CA1338878C (en) 1997-01-28
JP2983224B2 (ja) 1999-11-29
US5587460A (en) 1996-12-24
GR3021552T3 (en) 1997-02-28
DE68926916D1 (de) 1996-09-12
JPH0284192A (ja) 1990-03-26
EP0337799A3 (en) 1990-11-14

Similar Documents

Publication Publication Date Title
ES2096557T3 (es) Lectinas 14-beta-gal de mamiferos.
ES2051806T3 (es) Preparados de proteina humana estables.
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
ES2031806T3 (es) Factor de permeabilidad vascular humano.
ES2072918T3 (es) Mejoras en la produccion de polipeptidos.
ES545375A0 (es) Procedimiento para la fabricacion de materiales ceramicos autosoportantes
PA8426301A1 (es) Bikunina humana
ATE339507T1 (de) Erythropoietin-analog-menschliches serum-albumin fusionsprotein
AR017866A1 (es) Metodo para incrementar las inmunorespuestas de vacunas de acidos nucleicos, composiciones farmaceuticas de aplicacion en dicho metodo, procedimientopara preparar dichas composiciones y vacunas utilizadas en dicho metodo.
FI104255B1 (fi) Menetelmä ihmisen seerumialbumiinin N-terminaalifragmentteja sisältävien fuusioproteiinien valmistamiseksi
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
ES557670A0 (es) Un procedimiento para la produccion de una preparacion de activador de proteina c.
IT1240605B (it) Composizione farmaceutica solida e procedimento per la sua preparazione
DE3674764D1 (de) Transkutaner nagel zur fixierung von knochenfragmenten oder -teilen.
BR8703362A (pt) Composicao de adesivo,metodo para aglutinar material plastico e construcao aglutinada de adesivo de duas pecas
ES550713A0 (es) Procedimiento para la obtencion de dispersiones estables de poliureas y-o polihidrazodicarbonamidas
ES295060Y (es) Conjunto para el acondicionamiento y la presentacion de al menos un bloque de producto de consistencia solida
DK509485D0 (da) Toerstof til fremstilling af stabile suspensioner indeholdende 4-hydroxy- eller 4-acyloxy-4-androsten-3,17-dioner samt dets fremstilling og anvendelse
IT8519194A0 (it) Marcatura di un materiale proteico composizione di tecnezio-99m per la e procedimento.
MX169334B (es) Preparacion de liberacion sostenida
IT8920581A0 (it) Procedimento e impianto per la produzione di miscele cementizie iniettabili.
ES271812Y (es) Parte de construccion para la ereccion de edificaciones o partes de las mismas.
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
PT85951A (pt) Lanterna-portalil alimentada por bateria para emitir feixes de luz foscados e dispersos
MX158666A (es) Procedimiento para la fabricacion de tiras de fibra corta de material sintetico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 337799

Country of ref document: ES